BioCardia Newsroom

BioCardia Analyst Ratings

BenzingaNov 14 13:24 ET

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

BenzingaNov 14 13:24 ET

BioCardia's Strong Q3 Performance and Strategic Trials Drive Buy Rating

TipRanksNov 14 06:19 ET

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

BenzingaOct 28 11:18 ET

BioCardia Analyst Ratings

BenzingaOct 28 11:15 ET

H.C. Wainwright Maintains BioCardia(BCDA.US) With Buy Rating, Raises Target Price to $25

Moomoo NewsAug 22 09:31 ET

Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and CytomX Therapeutics (CTMX)

TipRanksAug 22 09:20 ET

BioCardia Analyst Ratings

BenzingaAug 21 13:34 ET

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

BenzingaAug 21 13:32 ET

BioCardia Analyst Ratings

BenzingaAug 16 13:50 ET

BioCardia Analyst Ratings

BenzingaJul 26 07:51 ET

H.C. Wainwright Maintains BioCardia(BCDA.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsJul 26 06:33 ET

BioCardia Analyst Ratings

BenzingaMay 29 13:30 ET

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $4 Price Target

BenzingaNov 14, 2023 11:22 ET

BioCardia Analyst Ratings

BenzingaNov 14, 2023 11:20 ET

Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and Femasys (FEMY)

TipRanksNov 14, 2023 10:40 ET

BioCardia's Strategic Clinical Advancements and Potential Growth Opportunities Prompt Buy Rating

TipRanksNov 9, 2023 06:51 ET

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $4 Price Target

BenzingaOct 11, 2023 12:35 ET

BioCardia Analyst Ratings

BenzingaOct 11, 2023 12:33 ET

HC Wainwright & Co. Maintains Buy on BioCardia, Lowers Price Target to $4

BenzingaSep 6, 2023 10:50 ET